January 29, 2015 10:00 AM ET


Company Overview of Tibotec-Virco NV

Company Overview

As of April 18, 2002, Tibotec-Virco NV was acquired by Johnson & Johnson. Tibotec-Virco NV and its subsidiaries operate as a biotechnology company. The company develops drugs and individualized disease management products, services, and technologies for HIV/AIDS. It has early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Mechelen, Belgium; Durham, North Carolina; and Dublin, Ireland, as well as in the United States and the United Kingdom. The company...

Gen De Wittelaan L 11B 3

Mechelen,  2800


Founded in 2001


32 1 529 31 00


32 1 528 63 47

Key Executives for Tibotec-Virco NV

Tibotec-Virco NV does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
UCB Pharma S.A. Europe
H-Phar S.A. Europe
Kemin Pharma bvba Europe
BioTech Tools SA Europe
SCS Boehringer Ingelheim Comm.V. Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tibotec-Virco NV, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.